REPLIGEN CORP (RGEN) Operating cash flow 2016–2025
REPLIGEN CORP (RGEN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$117.4MFY2025 · since FY2016: $7.5M → $117.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $117.4M | -33.1% |
| FY2024 | $175.4M | +54.0% |
| FY2023 | $113.9M | -33.8% |
| FY2022 | $172.1M | +44.6% |
| FY2021 | $119.0M | +90.0% |
| FY2020 | $62.6M | -6.8% |
| FY2019 | $67.2M | +105.1% |
| FY2018 | $32.8M | +87.8% |
| FY2017 | $17.5M | +132.0% |
| FY2016 | $7.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice